WaferGen Biosystems reported today an approximately eight-fold increase in revenues, but said that net loss swelled by more than 70 percent in the third quarter of 2010, the first full quarter of commercial availability for the company's flagship real-time PCR system.

Revenue for the quarter ended Sept. 30 grew to $633,000 from $79,000 for Q3 2009. Meantime, revenue for the first nine months of 2010 grew to $1.5 million compared to $190,000 in the same three quarters last year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.